Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Endocr Relat Cancer. 2020 Aug;27(8):T41–T52. doi: 10.1530/ERC-19-0435

Table 2.

Factors associated with metastatic risk in PPGLs

High risk Low risk
Tumor >5cm Tumor <5cm
Norepinephrine secretion Epinephrine secretion
Paraganglioma* Pheochromocytoma
Older age (sporadic) Younger age (sporadic and certain genetic groups)
SDHB, FH, SLC25A11 germline mutation VHL, RET mutation
ATRX, TERT, MAML3 somatic disruptions -
*

excluding head and neck paragangliomas, which have intrinsically low risk of metastasis